HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 82 filers reported holding HARVARD BIOSCIENCE INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,151,000 | -77.9% | 219,190 | -77.5% | 0.02% | -78.5% |
| Q2 2018 | $5,202,000 | +4.0% | 972,361 | -2.8% | 0.08% | -31.9% |
| Q1 2018 | $5,003,000 | +81.3% | 1,000,597 | +19.6% | 0.12% | +90.2% |
| Q4 2017 | $2,760,000 | -3.4% | 836,318 | +9.8% | 0.06% | -7.6% |
| Q3 2017 | $2,858,000 | +43.5% | 762,011 | -2.5% | 0.07% | +40.4% |
| Q2 2017 | $1,992,000 | +122.6% | 781,276 | +127.0% | 0.05% | +113.6% |
| Q1 2017 | $895,000 | -20.6% | 344,233 | -6.8% | 0.02% | -21.4% |
| Q4 2016 | $1,127,000 | +14.3% | 369,494 | +1.9% | 0.03% | +12.0% |
| Q3 2016 | $986,000 | +2.2% | 362,569 | +7.5% | 0.02% | 0.0% |
| Q2 2016 | $965,000 | – | 337,281 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,000,000 | $10,980,000 | 12.55% |
| 272 Capital LP | 3,062,963 | $16,815,667 | 6.18% |
| Meros Investment Management, LP | 813,014 | $4,463,447 | 2.21% |
| Harvey Partners, LLC | 2,524,000 | $13,856,760 | 1.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,862,649 | $15,715,943 | 0.96% |
| BARD ASSOCIATES INC | 286,922 | $1,575,202 | 0.61% |
| Acuitas Investments, LLC | 180,300 | $989,847 | 0.58% |
| Portolan Capital Management | 783,591 | $4,301,915 | 0.38% |
| Archon Capital Management LLC | 279,358 | $1,533,675 | 0.32% |
| HEARTLAND ADVISORS INC | 850,000 | $4,666,500 | 0.27% |